CancerLinQ Developing De-Identified Datasets for Quality Improvement | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

CancerLinQ Developing De-Identified Datasets for Quality Improvement

December 22, 2017
by
| Reprints

CancerLinQ LLC, a wholly-owned non-profit subsidiary of the American Society of Clinical Oncology (ASCO), announced new partnerships with data services companies Tempus and Precision HealthAI in order to accelerate development and delivery of high-quality, de-identified clinical databases for use by CancerLinQ, its oncologist subscribers, partners, and the broader cancer community.

The agreement will also enable CancerLinQ to more quickly build and expand on its core data sharing and quality improvement platform for oncology practices, and facilitate Tempus' and Precision HealthAI's connection to industry to support faster and better development of new treatments for patients, according to a CancerLinQ press release.

Through the new agreement, Tempus and Precision HealthAI will curate data into high-quality datasets to be used to improve quality of cancer care and for research. These datasets will be made available through the core CancerLinQ quality improvement platform and CancerLinQ Discovery, a service that provides access to high-quality, de-identified datasets for non-profit organizations, health care providers, academic researchers, and government agencies.

Tempus and Precision HealthAI will bring these de-identified datasets to industry partners to produce practical applications such as targeted therapies, more efficient clinical trials, and data-driven analyses to help determine which therapies are producing the greatest patient benefit. Royalties from this license will help to support ASCO's CancerLinQ initiative, according to the organization.

Under the new license arrangement, CancerLinQ will retain its non-profit status and remain responsible for data integration and providing a platform of meaningful tools and reports to participating oncologists and oncology care sites. Tempus and Precision HealthAI will be responsible for further structuring this dataset to put it to work for the benefit of patients.  

"Our commitment to oncologists and the patients they serve is stronger than ever and this collaboration will allow us to deliver cutting-edge clinical tools and enhanced benefits to the cancer centers participating in CancerLinQ,” CancerLinQ LLC chief executive officer Kevin Fitzpatrick said in a statement. “As a result of the technical and financial contributions of Tempus and Precision HealthAI, CancerLinQ aims to accelerate the pace of new quality improvement services to its subscribers.”

CancerLinQ recently reached a key milestone with more than 100 oncology practices in 40 states and the District of Columbia now signed up to participate. They account for more than 2,000 medical oncologists and have contributed more than a million cancer patient records in the database. 

 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Survey: Infrastructure, Interoperability Key Barriers to Global HIT Development

A new survey report from Black Book Research on global healthcare IT adoption and records systems connectivity finds nations in various phases of regional electronic health record (EHR) adoption. The survey results also reveal rapidly advancing opportunities for U.S.-based and local technology vendors.

Penn Medicine Opens Up Telehealth Hub

Philadelphia-based Penn Medicine has opened its Center for Connected Care to centralize the health system’s telemedicine activities.

Roche to Pay $1.9B for Flatiron Health

Switzerland-based pharmaceutical company Roche has agreed to pay $1.9 billion to buy New York-based Flatiron Health Inc., which has both an oncology EHR and data analytics platform.

Financial Exec Survey: Interoperability Key Obstacle to Value-Based Payment Models

Momentum continues to grow for value-based care as nearly three-quarters of healthcare executives report their organizations have achieved positive financial results from value-based payment programs, to date, according to a new study from the Healthcare Financial Management Association (HFMA).

Cerner, Children's National to Help UAE Pediatric Center with Health IT

Al Jalila Children's Specialty Hospital, the only pediatric hospital in the United Arab Emirates, has entered into an agreement with Washington, D.C.-based Children's National Health System to form a health IT strategic partnership.

Telemedicine Association Names New CEO

The American Telemedicine Association (ATA) has named Ann Mond Johnson its new CEO, replacing Jon Linkous who stepped down suddenly last August after 24 years as the organization’s CEO.